Pulse Biosciences partners with Clayman Thyroid Center to launch nPulse Vybrance System
Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center to treat benign thyroid nodules, advancing market development for its nanosecond pulsed field ablation technology.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed